180% return on Turmalina Metal... 217% on Galway Mining... 872% on Fosterville South...
These are just a few of the legendary Keith Schaefer’s returns from this year.
Trades he made with his own money… Had you invested $1,000 in each of those trades, you’d be sitting on an extra $23,880 right now!
Now he’s dumping his money into a new company — $58,000, to be exact... You're going to want to jump IN on this with Keith!Discover the 'SFC' Strategy Now!
A vaccine for the coronavirus is upon us — or at least that’s what investors are crossing their fingers for as they continue to look for the next best COVID-19 vaccine stock to buy.
Luckily it seems like we’re nearing the home stretch — big name companies like Pfizer Inc. (NYSE: PFE), Moderna Inc. (Nasdaq: MRNA) and AstraZeneva Plc. (Nasdaq: AZN)haved published successful preliminary results from the clinical trials of their vaccines.
But there can only be one leader in the race to discover a cure… And billionaire Bill Gates believes that he knows exactly which company that takes the title.
In an interview with CNBC News, Bill said “The only vaccine that, if everything went perfectly, might seek the emergency use license by the end of October, would be Pfizer.”
And so the race for a coronavirus vaccine continues with taking the spotlight once more.
People keeping up with the race already know Pfizer was one of the nine companies in September that took a stance to “stand with science” and not rush a vaccine that hasn’t been properly vetted.
The Food and Drug Administration is insisting on companies having at least two months of data on half of the people participating in the trial after their final dose before approving the Emergency Use Authorization.
Pfizer announced Friday it won’t apply its vaccine for emergency authorization until after the election — despite President Donald Trump insisting it would have a cure before the elections.
However, of the four companies currently in the late-stage testing phase of their vaccines, Pfizer’s aggressive timeline goals are beating Moderna, AstraZeneva and Johnson & Johnson (NYSE: JNJ).
With so many eyes on this company the past few months, the stock market has begun to take notice… and so has New Money Crew Head Trader Joshua Belanger.
You see, after taking a look at the charts Joshua noticed a major coronavirus vaccine play being made with the pay-off potential of $7.2 million… in the next 38 days… on a $1.1 million outlay.
If you want to take advantage of this actionable trade, then start trading Pfizer today! And as always, leave a comment down below — we’d love to hear your thoughts about today’s video!
P.S.As you may already know, many “Robinhood traders” have been flooding the stock market…
But what you probably don’t know is that they’ve overwhelmed Wall Street.
You see, the advantage is no longer in their hands… it’s in ours!
While some investors are sidelining themselves for the coming election… this group is preparing for massive capital floods.
And it could earn you up to 339% on your money every single week… If you miss this now, you’ll miss one of the best opportunities to profit that you’ll see in years.
Want to get ahead of the next Robinhood capital flood?